A chemogenomic approach seems indispensable for effective
treatment of amyotrophic lateral sclerosis
Georgios Pampalakis1*, Georgios
Angelis1, Pinelopi Kastana1, Kostas
Vekrellis2, Georgia Sotiropoulou3
1Department of Pharmacology-Pharmacognosy, School of
Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 541 24,
Greece
2Biomedical Research Foundation, Academy of Athens, 4
Soranou Ephessiou Str, 115 27, Athens, Greece
3Department of Pharmacy, School of Health Sciences,
University of Patras, Rion-Patras, 265 04, Greece
*Corresponding author
Tel: 2310 997638
E-mail: gpampalakis@pharm.auth.gr